English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 95 | Tables: 103 | Medical Devices & Consumables
The global market for Hemoperfusion Production was estimated to be worth US$ 763 million in 2024 and is forecast to a readjusted size of US$ 2051 million by 2031 with a CAGR of 15.4% during the forecast period 2025-2031.
Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient"s body.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion Production, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemoperfusion Production by region & country, by Type, and by Application.
The Hemoperfusion Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion Production.
Market Segmentation
By Company
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
Segment by Type
Resin Adsorption
Activated Carbon Adsorption
Others
Segment by Application
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemoperfusion Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemoperfusion Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemoperfusion Production in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Hemoperfusion Production Product Introduction
1.2 Global Hemoperfusion Production Market Size Forecast
1.2.1 Global Hemoperfusion Production Sales Value (2020-2031)
1.2.2 Global Hemoperfusion Production Sales Volume (2020-2031)
1.2.3 Global Hemoperfusion Production Sales Price (2020-2031)
1.3 Hemoperfusion Production Market Trends & Drivers
1.3.1 Hemoperfusion Production Industry Trends
1.3.2 Hemoperfusion Production Market Drivers & Opportunity
1.3.3 Hemoperfusion Production Market Challenges
1.3.4 Hemoperfusion Production Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemoperfusion Production Players Revenue Ranking (2024)
2.2 Global Hemoperfusion Production Revenue by Company (2020-2025)
2.3 Global Hemoperfusion Production Players Sales Volume Ranking (2024)
2.4 Global Hemoperfusion Production Sales Volume by Company Players (2020-2025)
2.5 Global Hemoperfusion Production Average Price by Company (2020-2025)
2.6 Key Manufacturers Hemoperfusion Production Manufacturing Base and Headquarters
2.7 Key Manufacturers Hemoperfusion Production Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemoperfusion Production
2.9 Hemoperfusion Production Market Competitive Analysis
2.9.1 Hemoperfusion Production Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemoperfusion Production Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion Production as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Resin Adsorption
3.1.2 Activated Carbon Adsorption
3.1.3 Others
3.2 Global Hemoperfusion Production Sales Value by Type
3.2.1 Global Hemoperfusion Production Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hemoperfusion Production Sales Value, by Type (2020-2031)
3.2.3 Global Hemoperfusion Production Sales Value, by Type (%) (2020-2031)
3.3 Global Hemoperfusion Production Sales Volume by Type
3.3.1 Global Hemoperfusion Production Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hemoperfusion Production Sales Volume, by Type (2020-2031)
3.3.3 Global Hemoperfusion Production Sales Volume, by Type (%) (2020-2031)
3.4 Global Hemoperfusion Production Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Overdose
4.1.2 Specific Intoxications
4.1.3 Certain Autoimmune Diseases
4.1.4 Hepatic Encephalopathy
4.1.5 Others
4.2 Global Hemoperfusion Production Sales Value by Application
4.2.1 Global Hemoperfusion Production Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hemoperfusion Production Sales Value, by Application (2020-2031)
4.2.3 Global Hemoperfusion Production Sales Value, by Application (%) (2020-2031)
4.3 Global Hemoperfusion Production Sales Volume by Application
4.3.1 Global Hemoperfusion Production Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hemoperfusion Production Sales Volume, by Application (2020-2031)
4.3.3 Global Hemoperfusion Production Sales Volume, by Application (%) (2020-2031)
4.4 Global Hemoperfusion Production Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hemoperfusion Production Sales Value by Region
5.1.1 Global Hemoperfusion Production Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hemoperfusion Production Sales Value by Region (2020-2025)
5.1.3 Global Hemoperfusion Production Sales Value by Region (2026-2031)
5.1.4 Global Hemoperfusion Production Sales Value by Region (%), (2020-2031)
5.2 Global Hemoperfusion Production Sales Volume by Region
5.2.1 Global Hemoperfusion Production Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hemoperfusion Production Sales Volume by Region (2020-2025)
5.2.3 Global Hemoperfusion Production Sales Volume by Region (2026-2031)
5.2.4 Global Hemoperfusion Production Sales Volume by Region (%), (2020-2031)
5.3 Global Hemoperfusion Production Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hemoperfusion Production Sales Value, 2020-2031
5.4.2 North America Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hemoperfusion Production Sales Value, 2020-2031
5.5.2 Europe Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hemoperfusion Production Sales Value, 2020-2031
5.6.2 Asia Pacific Hemoperfusion Production Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hemoperfusion Production Sales Value, 2020-2031
5.7.2 South America Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemoperfusion Production Sales Value, 2020-2031
5.8.2 Middle East & Africa Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemoperfusion Production Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hemoperfusion Production Sales Value
6.2.1 Key Countries/Regions Hemoperfusion Production Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hemoperfusion Production Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hemoperfusion Production Sales Value, 2020-2031
6.3.2 United States Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hemoperfusion Production Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hemoperfusion Production Sales Value, 2020-2031
6.4.2 Europe Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hemoperfusion Production Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hemoperfusion Production Sales Value, 2020-2031
6.5.2 China Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hemoperfusion Production Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hemoperfusion Production Sales Value, 2020-2031
6.6.2 Japan Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hemoperfusion Production Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hemoperfusion Production Sales Value, 2020-2031
6.7.2 South Korea Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hemoperfusion Production Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hemoperfusion Production Sales Value, 2020-2031
6.8.2 Southeast Asia Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hemoperfusion Production Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hemoperfusion Production Sales Value, 2020-2031
6.9.2 India Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hemoperfusion Production Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Jafron Biomedical
7.1.1 Jafron Biomedical Company Information
7.1.2 Jafron Biomedical Introduction and Business Overview
7.1.3 Jafron Biomedical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Jafron Biomedical Hemoperfusion Production Product Offerings
7.1.5 Jafron Biomedical Recent Development
7.2 Baxter (Gambro)
7.2.1 Baxter (Gambro) Company Information
7.2.2 Baxter (Gambro) Introduction and Business Overview
7.2.3 Baxter (Gambro) Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Baxter (Gambro) Hemoperfusion Production Product Offerings
7.2.5 Baxter (Gambro) Recent Development
7.3 Biosun Medical
7.3.1 Biosun Medical Company Information
7.3.2 Biosun Medical Introduction and Business Overview
7.3.3 Biosun Medical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Biosun Medical Hemoperfusion Production Product Offerings
7.3.5 Biosun Medical Recent Development
7.4 Toray Medical
7.4.1 Toray Medical Company Information
7.4.2 Toray Medical Introduction and Business Overview
7.4.3 Toray Medical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Toray Medical Hemoperfusion Production Product Offerings
7.4.5 Toray Medical Recent Development
7.5 Asahi-Kasei
7.5.1 Asahi-Kasei Company Information
7.5.2 Asahi-Kasei Introduction and Business Overview
7.5.3 Asahi-Kasei Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Asahi-Kasei Hemoperfusion Production Product Offerings
7.5.5 Asahi-Kasei Recent Development
7.6 Kaneka
7.6.1 Kaneka Company Information
7.6.2 Kaneka Introduction and Business Overview
7.6.3 Kaneka Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Kaneka Hemoperfusion Production Product Offerings
7.6.5 Kaneka Recent Development
7.7 Zibo Kangbei
7.7.1 Zibo Kangbei Company Information
7.7.2 Zibo Kangbei Introduction and Business Overview
7.7.3 Zibo Kangbei Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Zibo Kangbei Hemoperfusion Production Product Offerings
7.7.5 Zibo Kangbei Recent Development
7.8 Aier
7.8.1 Aier Company Information
7.8.2 Aier Introduction and Business Overview
7.8.3 Aier Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Aier Hemoperfusion Production Product Offerings
7.8.5 Aier Recent Development
7.9 Cytosorbents
7.9.1 Cytosorbents Company Information
7.9.2 Cytosorbents Introduction and Business Overview
7.9.3 Cytosorbents Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Cytosorbents Hemoperfusion Production Product Offerings
7.9.5 Cytosorbents Recent Development
8 Industry Chain Analysis
8.1 Hemoperfusion Production Industrial Chain
8.2 Hemoperfusion Production Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemoperfusion Production Sales Model
8.5.2 Sales Channel
8.5.3 Hemoperfusion Production Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hemoperfusion Production Market Trends
Table 2. Hemoperfusion Production Market Drivers & Opportunity
Table 3. Hemoperfusion Production Market Challenges
Table 4. Hemoperfusion Production Market Restraints
Table 5. Global Hemoperfusion Production Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Hemoperfusion Production Revenue Market Share by Company (2020-2025)
Table 7. Global Hemoperfusion Production Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Hemoperfusion Production Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Hemoperfusion Production Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Hemoperfusion Production Manufacturing Base and Headquarters
Table 11. Key Manufacturers Hemoperfusion Production Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Hemoperfusion Production
Table 13. Global Hemoperfusion Production Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion Production as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemoperfusion Production Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Hemoperfusion Production Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Hemoperfusion Production Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Hemoperfusion Production Sales Market Share in Value by Type (2020-2025)
Table 20. Global Hemoperfusion Production Sales Market Share in Value by Type (2026-2031)
Table 21. Global Hemoperfusion Production Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Hemoperfusion Production Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Hemoperfusion Production Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Hemoperfusion Production Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Hemoperfusion Production Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Hemoperfusion Production Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Hemoperfusion Production Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Hemoperfusion Production Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Hemoperfusion Production Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Hemoperfusion Production Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Hemoperfusion Production Sales Market Share in Value by Application (2020-2025)
Table 32. Global Hemoperfusion Production Sales Market Share in Value by Application (2026-2031)
Table 33. Global Hemoperfusion Production Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Hemoperfusion Production Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Hemoperfusion Production Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Hemoperfusion Production Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Hemoperfusion Production Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Hemoperfusion Production Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Hemoperfusion Production Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Hemoperfusion Production Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Hemoperfusion Production Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Hemoperfusion Production Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Hemoperfusion Production Sales Value by Region (2020-2025) & (%)
Table 44. Global Hemoperfusion Production Sales Value by Region (2026-2031) & (%)
Table 45. Global Hemoperfusion Production Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Hemoperfusion Production Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Hemoperfusion Production Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Hemoperfusion Production Sales Volume by Region (2020-2025) & (%)
Table 49. Global Hemoperfusion Production Sales Volume by Region (2026-2031) & (%)
Table 50. Global Hemoperfusion Production Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Hemoperfusion Production Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Hemoperfusion Production Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Hemoperfusion Production Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Hemoperfusion Production Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Hemoperfusion Production Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Hemoperfusion Production Sales Volume, (2026-2031) & (K Units)
Table 57. Jafron Biomedical Company Information
Table 58. Jafron Biomedical Introduction and Business Overview
Table 59. Jafron Biomedical Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Jafron Biomedical Hemoperfusion Production Product Offerings
Table 61. Jafron Biomedical Recent Development
Table 62. Baxter (Gambro) Company Information
Table 63. Baxter (Gambro) Introduction and Business Overview
Table 64. Baxter (Gambro) Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Baxter (Gambro) Hemoperfusion Production Product Offerings
Table 66. Baxter (Gambro) Recent Development
Table 67. Biosun Medical Company Information
Table 68. Biosun Medical Introduction and Business Overview
Table 69. Biosun Medical Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Biosun Medical Hemoperfusion Production Product Offerings
Table 71. Biosun Medical Recent Development
Table 72. Toray Medical Company Information
Table 73. Toray Medical Introduction and Business Overview
Table 74. Toray Medical Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Toray Medical Hemoperfusion Production Product Offerings
Table 76. Toray Medical Recent Development
Table 77. Asahi-Kasei Company Information
Table 78. Asahi-Kasei Introduction and Business Overview
Table 79. Asahi-Kasei Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Asahi-Kasei Hemoperfusion Production Product Offerings
Table 81. Asahi-Kasei Recent Development
Table 82. Kaneka Company Information
Table 83. Kaneka Introduction and Business Overview
Table 84. Kaneka Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Kaneka Hemoperfusion Production Product Offerings
Table 86. Kaneka Recent Development
Table 87. Zibo Kangbei Company Information
Table 88. Zibo Kangbei Introduction and Business Overview
Table 89. Zibo Kangbei Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Zibo Kangbei Hemoperfusion Production Product Offerings
Table 91. Zibo Kangbei Recent Development
Table 92. Aier Company Information
Table 93. Aier Introduction and Business Overview
Table 94. Aier Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Aier Hemoperfusion Production Product Offerings
Table 96. Aier Recent Development
Table 97. Cytosorbents Company Information
Table 98. Cytosorbents Introduction and Business Overview
Table 99. Cytosorbents Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Cytosorbents Hemoperfusion Production Product Offerings
Table 101. Cytosorbents Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Hemoperfusion Production Downstream Customers
Table 105. Hemoperfusion Production Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemoperfusion Production Product Picture
Figure 2. Global Hemoperfusion Production Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Hemoperfusion Production Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Hemoperfusion Production Sales Volume (2020-2031) & (K Units)
Figure 5. Global Hemoperfusion Production Sales Price (2020-2031) & (USD/Unit)
Figure 6. Hemoperfusion Production Report Years Considered
Figure 7. Global Hemoperfusion Production Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Hemoperfusion Production Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hemoperfusion Production Revenue in 2024
Figure 10. Hemoperfusion Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Resin Adsorption Picture
Figure 12. Activated Carbon Adsorption Picture
Figure 13. Others Picture
Figure 14. Global Hemoperfusion Production Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Hemoperfusion Production Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Hemoperfusion Production Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Hemoperfusion Production Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Hemoperfusion Production Price by Type (2020-2031) & (USD/Unit)
Figure 19. Product Picture of Overdose
Figure 20. Product Picture of Specific Intoxications
Figure 21. Product Picture of Certain Autoimmune Diseases
Figure 22. Product Picture of Hepatic Encephalopathy
Figure 23. Product Picture of Others
Figure 24. Global Hemoperfusion Production Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 25. Global Hemoperfusion Production Sales Value Market Share by Application, 2024 & 2031
Figure 26. Global Hemoperfusion Production Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 27. Global Hemoperfusion Production Sales Volume Market Share by Application, 2024 & 2031
Figure 28. Global Hemoperfusion Production Price by Application (2020-2031) & (USD/Unit)
Figure 29. North America Hemoperfusion Production Sales Value (2020-2031) & (US$ Million)
Figure 30. North America Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
Figure 31. Europe Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
Figure 33. Asia Pacific Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Hemoperfusion Production Sales Value by Region (%), 2024 VS 2031
Figure 35. South America Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 36. South America Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
Figure 37. Middle East & Africa Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 38. Middle East & Africa Hemoperfusion Production Sales Value by Country (%), 2024 VS 2031
Figure 39. Key Countries/Regions Hemoperfusion Production Sales Value (%), (2020-2031)
Figure 40. Key Countries/Regions Hemoperfusion Production Sales Volume (%), (2020-2031)
Figure 41. United States Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 42. United States Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 43. United States Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 44. Europe Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 46. Europe Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 47. China Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 48. China Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 49. China Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 50. Japan Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 51. Japan Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 52. Japan Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 53. South Korea Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 54. South Korea Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 55. South Korea Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 56. Southeast Asia Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 57. Southeast Asia Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 58. Southeast Asia Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 59. India Hemoperfusion Production Sales Value, (2020-2031) & (US$ Million)
Figure 60. India Hemoperfusion Production Sales Value by Type (%), 2024 VS 2031
Figure 61. India Hemoperfusion Production Sales Value by Application (%), 2024 VS 2031
Figure 62. Hemoperfusion Production Industrial Chain
Figure 63. Hemoperfusion Production Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
